Laurent raises VC financing to advance cystic fibrosis drug
Montréal-based biopharmaceutical company Laurent Pharmaceuticals Inc has raised an undisclosed financing. The round was led by Keiretsu Forum Mid-Atlantic, Anges Québec and Anges Québec Capital. They were joined by RSJ Gradus, Aligo Innovation, Cystic Fibrosis Canada and other investors. President and CEO Radu Pislariu said the funds raised will help the company build on progress made developing LAU-7b, a first-in-class, pro-resolving drug for treating cystic fibrosis. Laurent was founded in 2012 in a partnership between MSBi Valorisation, McGill University and McGill University Health Centre.
25 October 2018•4 mins read
